Park Medi World’s initial public offering (IPO), targeting around ₹920 crore, is in its third and final day. Priced between ₹154 and ₹162 per share, the IPO includes a mix of new shares and shares sold by existing investors.
In the grey market, where unofficial trades hint at potential listing gains, the premium has eased to around ₹8–₹9 per share, roughly 5% above the issue price. This marks a softening from earlier levels, signaling a slight cooling of short-term trading excitement.
By the end of Day 2, the IPO was almost fully subscribed. Retail investors applied for 1.19 times their allocation, while non-institutional investors applied for 1.38 times. Institutional investors were more cautious, covering only 32% of their quota.
The company plans to use the proceeds to repay debt, expand its hospital network, purchase medical equipment, and fund growth initiatives. Park Medi World operates 14 multi-speciality hospitals in North India, with over 3,000 beds and more than 30 medical specialties, making it a significant player in the region’s healthcare sector.
Financially, the company has reported steady growth in revenue and profits over the past few years. Its expansion strategy, through acquisitions and new hospital projects, has helped strengthen its position in the competitive healthcare market.
Analysts see the IPO as attractive for long-term investors, highlighting the company’s strong fundamentals and the rising demand for quality healthcare services across India.
The IPO closes on 12 December 2025, with listing expected later this month. Investors are watching both subscription trends and grey market movements closely, as they offer a glimpse into potential listing performance.
Park Medi World’s offering reflects continued investor interest in the healthcare sector, combining growth potential with an established hospital network and a wide range of specialized services.